{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T04:12:33Z","timestamp":1772856753324,"version":"3.50.1"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"10","funder":[{"name":"Theravance Biopharma Antibiotics, Inc."},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>MRSA strains of clonal complexes (CCs) 5, 8, 30 and 45 are leading causes of complicated endovascular infections associated with suboptimal clinical outcomes. Telavancin is a novel anti-MRSA agent that both inhibits bacterial cell wall synthesis and disrupts membranes by depolarization.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this study, we compared the in vitro susceptibility and in vivo efficacy of telavancin versus daptomycin in an experimental rabbit infective endocarditis (IE) model caused by four MRSA strains representing each of the above CC types.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>All study strains were susceptible to telavancin (MICs of \u22640.12 mg\/L) and daptomycin (MICs of \u22640.5 mg\/L). In vitro time\u2013kill analyses revealed that supra-MIC levels of telavancin were effective at preventing regrowth at 24 h of incubation. In the IE animal model for all CC types, treatment with telavancin produced significantly greater reductions in MRSA counts as compared with daptomycin-treated animals in all target tissues. Moreover, telavancin-treated animals had a significantly higher percentage of sterile tissue cultures versus daptomycin-treated animals (e.g. 78%\u2013100% versus 0% sterile vegetations and 100% versus 0%\u201311% sterile kidneys and spleen, in the telavancin- and daptomycin-treated animals, respectively).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These results suggest that telavancin exhibits significantly greater efficacies versus daptomycin in treating experimental IE caused by MRSA clinical isolates across four common CC types.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkw249","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T15:24:16Z","timestamp":1467213856000},"page":"2890-2894","source":"Crossref","is-referenced-by-count":12,"title":["Comparative efficacy of telavancin and daptomycin in experimental\n          endocarditis due to multi-clonotype MRSA strains"],"prefix":"10.1093","volume":"71","author":[{"given":"Yan Q.","family":"Xiong","sequence":"first","affiliation":[{"name":"Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA"},{"name":"David Geffen School of Medicine at UCLA, Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wessam","family":"Abdelhady","sequence":"first","affiliation":[{"name":"Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chieh \u2018Genna\u2019","family":"Tang","sequence":"first","affiliation":[{"name":"Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold S.","family":"Bayer","sequence":"first","affiliation":[{"name":"Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA"},{"name":"David Geffen School of Medicine at UCLA, Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,6,26]]},"reference":[{"key":"2020071611594460500_DKW249C1","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1001\/jama.293.24.3012","article-title":"Staphylococcus aureus\n            endocarditis: a consequence of medical progress","volume":"293","author":"Fowler","year":"2005","journal-title":"JAMA"},{"key":"2020071611594460500_DKW249C2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/00365540500372846","article-title":"Persistence in Staphylococcus\n              aureus bacteremia: incidence, characteristics of patients and\n            outcome","volume":"38","author":"Khatib","year":"2006","journal-title":"Scan J Infect\n            Dis"},{"key":"2020071611594460500_DKW249C3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/595738","article-title":"Phenotypic and genotypic characteristics of\n            persistent methicillin-resistant Staphylococcus aureus bacteremia in\n            vitro and in an experimental endocarditis model","volume":"199","author":"Xiong","year":"2009","journal-title":"J\n              Infect Dis"},{"key":"2020071611594460500_DKW249C4","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.1128\/AAC.00922-12","article-title":"Telavancin in therapy of experimental aortic\n            valve endocarditis in rabbits due to daptomycin-nonsusceptible methicillin-resistant\n              Staphylococcus aureus","volume":"56","author":"Xiong","year":"2012","journal-title":"Antimicrob\n              Agents Chemother"},{"key":"2020071611594460500_DKW249C5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/QCO.0b013e32834ab1de","article-title":"New Gram-positive antibiotics: better than\n              vancomycin?","volume":"24","author":"van Hal","year":"2011","journal-title":"Curr Opin Infect\n            Dis"},{"key":"2020071611594460500_DKW249C6","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1128\/AAC.02330-13","article-title":"Telavancin for hospital-acquired pneumonia:\n            clinical response and 28-day survival","volume":"58","author":"Corey","year":"2014","journal-title":"Antimicrob Agents\n              Chemother"},{"key":"2020071611594460500_DKW249C7","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1086\/520088","article-title":"Potential associations between hematogenous\n            complications and bacterial genotype in Staphylococcus aureus\n            infection","volume":"196","author":"Fowler","year":"2007","journal-title":"J Infect\n            Dis"},{"key":"2020071611594460500_DKW249C8","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/infdis\/jir389","article-title":"Methicillin-susceptible\n              Staphylococcus aureus endocarditis isolates are associated with\n            clonal complex 30 genotype and a distinct repertoire of enterotoxins and\n            adhesins","volume":"204","author":"Nienaber","year":"2011","journal-title":"J Infect\n            Dis"},{"key":"2020071611594460500_DKW249C9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for\n            bacteremia and endocarditis caused by Staphylococcus\n            aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"New Eng J\n            Med"},{"key":"2020071611594460500_DKW249C10","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/jac\/dku547","article-title":"Early agr activation correlates with vancomycin\n            treatment failure in multi-clonotype MRSA endovascular infections","volume":"70","author":"Abdelhady","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2020071611594460500_DKW249C11","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1128\/AAC.05251-11","article-title":"Relationship of agr expression and function\n            with virulence and vancomycin treatment outcomes in experimental endocarditis due to\n            methicillin-resistant Staphylococcus aureus","volume":"55","author":"Seidl","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2020071611594460500_DKW249C12","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/AAC.01028-10","article-title":"Combinatorial phenotypic signatures\n            distinguish persistent from resolving methicillin-resistant Staphylococcus\n              aureus bacteremia isolates","volume":"55","author":"Seidl","year":"2011","journal-title":"Antimicrob Agents\n              Chemother"},{"key":"2020071611594460500_DKW249C13","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0140-6736(06)68231-7","article-title":"Complete genome sequence of USA300, an epidemic\n            clone of community-acquired meticillin-resistant Staphylococcus\n            aureus","volume":"367","author":"Diep","year":"2006","journal-title":"Lancet"},{"key":"2020071611594460500_DKW249C14","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1128\/AAC.03172-14","article-title":"Revised reference broth microdilution method\n            for testing telavancin: effect on MIC results and correlation with other testing\n            methodologies","volume":"58","author":"Farrell","year":"2014","journal-title":"Antimicrob Agents\n            Chemother"},{"key":"2020071611594460500_DKW249C15","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1128\/AAC.49.8.3163-3165.2005","article-title":"Efficacy of telavancin in a rabbit model of aortic valve endocarditis due\n            to methicillin-resistant Staphylococcus aureus or\n            vancomycin-intermediate Staphylococcus aureus","volume":"49","author":"Madrigal","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2020071611594460500_DKW249C16","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1128\/AAC.01101-08","article-title":"Comparative efficacies of telavancin and vancomycin in preventing\n            device-associated colonization and infection by Staphylococcus aureus\n            in rabbits","volume":"53","author":"Darouiche","year":"2009","journal-title":"Antimicrob Agents\n            Chemother"},{"key":"2020071611594460500_DKW249C17","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1128\/AAC.01307-08","article-title":"Relationship between susceptibility to\n            daptomycin in vitro and activity in vivo in a rabbit model of aortic valve\n            endocarditis","volume":"53","author":"Chambers","year":"2009","journal-title":"Antimicrob Agents\n            Chemother"},{"key":"2020071611594460500_DKW249C18","first-page":"205","article-title":"Improved understanding of factors driving methicillin-resistant\n              Staphylococcus aureus epidemic waves","volume":"5","author":"Chatterjee","year":"2013","journal-title":"Clin Epidemiology"},{"key":"2020071611594460500_DKW249C19","first-page":"629","article-title":"Waves of resistance: Staphylococcus aureus in the\n            antibiotic era","volume":"7","author":"Chambers","year":"2009","journal-title":"Nature\n            Reviews"},{"key":"2020071611594460500_DKW249C20","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/AAC.01266-06","article-title":"Efficacy of telavancin in the treatment of\n            experimental endocarditis due to glycopeptide-intermediate Staphylococcus\n              aureus","volume":"51","author":"Miro","year":"2007","journal-title":"Antimicrob Agents\n            Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/71\/10\/2890\/28888477\/dkw249.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/71\/10\/2890\/28888477\/dkw249.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T18:25:04Z","timestamp":1594923904000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/71\/10\/2890\/2388654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,26]]},"references-count":20,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,6,26]]},"published-print":{"date-parts":[[2016,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkw249","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2016,10]]},"published":{"date-parts":[[2016,6,26]]}}}